2.9. Antifungal Drug Susceptibility Assays

MG Manuela Gómez-Gaviria
NL Nancy E. Lozoya-Pérez
MS Monika Staniszewska
BF Bernardo Franco
GN Gustavo A. Niño-Vega
HM Hector M. Mora-Montes
request Request a Protocol
ask Ask a question
Favorite

The susceptibility to antifungal drugs was performed as described in the M27-A3 yeast microdilution test, standardized by the CLSI [44]. For the water-soluble antifungal drugs, a stock solution of 64 μg/mL was prepared using RPMI 1640 as diluent. For amphotericin B, a stock solution of 16 μg/mL was prepared using DMSO as diluent. In all cases, 10-fold dilutions series were prepared for incubation with fungal cells. A 5 h culture of C. albicans was washed with PBS and the O.D.530 nm adjusted to 0.5. Then, a 1:1000 dilution was prepared with RPMI 1640 medium (supplemented with glutamine and without sodium bicarbonate, buffered with 0.164 M morpholino propanesulfonic acid, adjusted to pH 7 and with 0.2% (w/v) glucose) and this dilution was used to inoculate 100 μL in flat-bottom 96-well plates. As controls, wells only with the medium were included. The antifungal dilutions were included in aliquots of 100 µL per well and plates were incubated at 37 °C for 24 h and gently shaken. Then, the absorbance of the plates was measured at 490 nm and 530 nm with a Multiskan™ FC microplate photometer (Thermo).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A